Just two weeks after the multi-million dollar deal with US cancer specialist OncoC4, BioNTech has established another partnership - this time a multi-billion dollar...
Vaccines against infection or serious illness caused by respiratory syncytial virus (RSV) for the elderly could be available soon. Successful studies recently appeared...
The EU medicines agency EMA has warned of the declining effectiveness of several antibody-based corona drugs against the latest sub-variants of the virus. ...